| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |